Drug Trial Radar · NCT05170841
Study Evaluating Dexketoprofen Trometamol/Tramadol Hydrochloride Analgesic Efficacy in Acute Low Back Pain
Last checked: Nov 20, 2026Latest source record: Jan 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
538
Actual
Start
Sep 17, 2020
Primary completion
May 4, 2022
Study completion May 4, 2022
Sponsor
- Lead sponsor
- Menarini International Operations Luxembourg SAIndustry
- Sponsor type
- Industry
- First posted
- Dec 28, 2021
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A randomized, double-blind, study to evaluate the analgesic efficacy and safety of Dexketoprofen trometamol and Tramadol hydrochloride combination versus placebo on moderate to severe acute pain in patients with acute low back pain.
Conditions
- Low Back Pain
Interventions
Dexketoprofen Trometamol 25 mg/Tramadol Hydrochloride 75 mgDrug
Administered as one single tablet to be taken every 8 hours
Tramadol Hydrochloride 100 mgDrug
Administered as two capsules with 50 mg each to be taken every 8 hours
PlaceboDrug
Administered as one tablet if matching Dexketoprofen Trometamol 25 mg and Tramadol Hydrochloride 75 mg or two capsules if matching Tramadol Hydrochloride 100 mg
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to First Achieve a Numeric Rating Scale-Pain Intensity Score <4 or a Pain Intensity Reduction of ≥30% From Drug Intake Till 8 Hours After the First DoseTime frame: 8 hours from first intake (referring to first 8 hours of Single Dose Phase)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of L'Aquila
L’Aquila, Italy
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.